Comparison of Drug-Eluting Versus Bare Metal Stents on Later Frequency of Acute Myocardial Infarction and Death

This publication has 29 references indexed in Scilit:

• Narrative Review: Drug-Eluting Stents for the Management of Restenosis: A Critical Appraisal of the Evidence
  Annals of Internal Medicine, 2006
• Drug-Eluting Stents Are Safe and Effective: Right or Wrong?
  Journal of the American College of Cardiology, 2006
• Correlates and Long-Term Outcomes of Angiographically Proven Stent Thrombosis With Sirolimus- and Paclitaxel-Eluting Stents
  Circulation, 2006
• Are Drug-Eluting Stents the Preferred Treatment for Multivessel Coronary Artery Disease?
  Journal of the American College of Cardiology, 2006
• Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)
  The Lancet, 2005
• Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
  JAMA, 2005
• Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation.
  Published by Oxford University Press (OUP) ,2004
• Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent
  Circulation, 2004
• A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
  New England Journal of Medicine, 2004
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003